cas 160052-43-7|| where to buy [3-[tert-butyl(diphenyl)silyl]oxy-2,2-difluoro-propyl] trifluoromethanesulfonate

Название продукции:[3-[tert-butyl(diphenyl)silyl]oxy-2,2-difluoro-propyl] trifluoromethanesulfonate

IUPAC Name:3-[(tert-butyldiphenylsilyl)oxy]-2,2-difluoropropyl trifluoromethanesulfonate

: CAS：160052-43-7; Молекулярная формула：C20H23F5O4SSi; Чистота：95%

Упаковочная единица	Доступно для заказа	Цена ($)
CM1076223-100mg	in stock	ǵȎǤ
CM1076223-250mg	in stock	ŉŉǵ
CM1076223-500mg	in stock	ǊŢư
CM1076223-1g	in stock	ưǤĽ
CM1076223-5g	in stock	ǵƄǵŉ
CM1076223-10g	in stock	ǊǤƄǵ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 160052-43-7 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:160052-43-7; Молекулярная формула:C20H23F5O4SSi; Точка плавления:-; Smiles-код:CC(C)(C)[Si](OCC(F)(F)COS(=O)(=O)C(F)(F)F)(C1=CC=CC=C1)C1=CC=CC=C1; Плотность:

: Номер в каталоге:CM1076223; Молекулярная масса:482.54; Точка кипения:; Номер Mdl:; Хранение:

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.